708305-Awarded - Poland – Pharmaceutical products – Supply of a medicinal product containing the active substance Mirvetuximab soravtansinum referred under the B.50 drug program. Treatment of patients with ovarian cancer, fallopian tube cancer or peritoneal cancer.

This tender with title 708305-Awarded - Poland – Pharmaceutical products – Supply of a medicinal product containing the active substance Mirvetuximab soravtansinum referred under the B.50 drug program. Treatment of patients with ovarian cancer, fallopian tube cancer or peritoneal cancer. -- Contract Value: 1 814 398,96 PLN has been published on Bidding Source portal dated 31 Oct 2025 for the country of Poland. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.